Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Somanetics receives 510(k) for INVOS technology:

This article was originally published in Clinica

Executive Summary

US company Somanetics has received a 510(k) clearance from the FDA to market its next generation Cerebral Oximeter. The new patient monitoring system offers technological advances over the current model such as its ability to monitor blood oxygen levels on both sides of the brain simultaneously using two disposable, single-use SomaSensors. It also has automatic calibration and respond faster to physiologic changes.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT086342

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel